In the high-stakes world of clinical trials, there is a pervasive misconception among executives that "more sites" and "big-name institutions" are the silver bullets for meeting enrollment deadlines. The logic seems sound: partner with a subject matter expert at a world-renowned hospital to gain instant credibility and access to vast patient pools.

Securing government funding is a major milestone for any life sciences company—preserving runway and validating your science. But why does the transition to active clinical execution so often lead to gridlock?

Tips for a successful clinical trial